A key regulator of colon cancer
The team headed by Angel Rodríguez Nebreda, ICREA researcher at IRB, identifies for the first time in mice that the p38 MAPK protein is required for the survival and proliferation of colon cancer cells. In the same study the scientists demonstrate that a p38 inhibitor that has been used in clinical trials for inflammatory diseases […]
